Robert Peter Kadlec

Insider Reports History

Location
New York, NY
Signature
By: /s/ Christine Klaskin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Peter Kadlec:

Company Role Class Num Shares Value Price $ Report Date Ownership
MiNK Therapeutics, Inc. Director Common Stock 19,126 $212,107 $11.09 01 Dec 2025 Direct
MiNK Therapeutics, Inc. Director Stock Option 41,745 30 Oct 2024 Direct
MiNK Therapeutics, Inc. Director Stock Option (Right to Buy) 3,225 09 Sep 2025 Direct

Insider Reports Filed by Robert Peter Kadlec

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INKT MiNK Therapeutics, Inc. 01 Dec 2025 1 +$13,508 4 Director 03 Dec 2025, 16:10
INKT MiNK Therapeutics, Inc. 09 Sep 2025 1 $0 4 Director 11 Sep 2025, 16:05
INKT MiNK Therapeutics, Inc. 02 Sep 2025 1 +$13,514 4 Director 03 Sep 2025, 17:30
INKT MiNK Therapeutics, Inc. 02 Jun 2025 1 +$13,501 4 Director 04 Jun 2025, 16:05
INKT MiNK Therapeutics, Inc. 03 Mar 2025 1 +$13,501 4 Director 05 Mar 2025, 16:05
INKT MiNK Therapeutics, Inc. 30 Oct 2024 2 +$8,969 4 Director 09 Dec 2024, 16:10
INKT MiNK Therapeutics, Inc. 30 Oct 2024 0 $0 3 Director 09 Dec 2024, 16:05